Baggs, James

Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections — United States

Kourtis, A. P., Hatfield, K., Baggs, J., Mu, Y., See, I., Epson, E., Nadle, J., Kainer, M. A., Dumyati, G., Petit, S., et al. (2019) · MMWR. Morbidity and Mortality Weekly Report

Antimicrobial Resistance in StaphylococcusAntibiotic Use and Resistance

Cited by 701

Multidrug-resistant bacterial infections in U.S. hospitalized patients, 2012-2017.

Jernigan, J. A., Hatfield, K. M., Wolford, H., Nelson, R. E., Olubajo, B., Reddy, S. C., McCarthy, N., Paul, P., McDonald, L. C., Kallen, A., et al. (2020) · New England Journal of Medicine

Antibiotic Resistance in BacteriaAntibiotic Use and Resistance

Cited by 577

Risk of subsequent sepsis within 90 days after a hospital stay by type of antibiotic exposure.

Baggs, J., Jernigan, J. A., Halpin, A. L., Epstein, L., Hatfield, K. M., & McDonald, L. C. (2018) · Clinical Infectious Diseases

Antibiotic Use and ResistanceSepsis Diagnosis and Treatment

Cited by 190

Candida auris‒Associated Hospitalizations, United States, 2017–2022

Benedict, K., Forsberg, K., Gold, J. A. W., Baggs, J., & Lyman, M. (2023) · Emerging Infectious Diseases

Antifungal resistance and susceptibilityYeasts and Rust Fungi Studies

Cited by 73

Trends in antifungal use in US hospitals, 2006–12

Vallabhaneni, S., Baggs, J., Tsay, S., Srinivasan, A. R., Jernigan, J. A., & Jackson, B. R. (2018) · Journal of Antimicrobial Chemotherapy

Antifungal resistance and susceptibilityAntibiotic Use and Resistance

Cited by 45

Reactogenicity within 2 weeks after mRNA COVID-19 vaccines: Findings from the CDC v-safe surveillance system

Chapin-Bardales, J., Myers, T., Gee, J., Shay, D. K., Marquez, P., Baggs, J., Zhang, B., Licata, C., & Shimabukuro, T. T. (2021) · Vaccine

SARS-CoV-2 and COVID-19 ResearchPharmacovigilance and Adverse Drug Reactions

Cited by 23